Dosing

The below doses are based on scientific research, publications, traditional use, or expert opinion. Many herbs and supplements have not been thoroughly tested, and safety and effectiveness may not be proven. Brands may be made differently, with variable ingredients, even within the same brand. The below doses may not apply to all products. You should read product labels, and discuss doses with a qualified healthcare provider before starting therapy.

Adults (18 years and older)

For alcohol intoxication, six 500 milligram capsules of EPO have been taken by mouth daily for one week.

For bronchitis, one tablet of a thyme-primrose combination product (Bronchipret® TP FCT) has been taken by mouth three times daily for 11 days. Two other combination products, Bronchicum® Elixir S and Bronchcium® Tropfen, have been taken by mouth in doses of 6 x 5 milliliters of fluid or 5 x 1 milliliter of drops for 7-9 days.

For breast pain (mastalgia), 1-3 grams or 2.4 milliliters of EPO, 1-6 capsules of EPO, or 240-320 milligrams of GLA (Efamast®, Efamol®) has been taken by mouth 1-3 times daily for up to six months.

For heart health, 10-30 milliliters of EPO (Efamol®) has been taken by mouth daily for four months. Additionally, 3 grams of a linoleic-GLA combination has been taken by mouth for two months.

For childbirth (labor induction or cervical ripening), one EPO capsule has been taken by mouth three times daily for one week.

For diabetes, two Efamol® capsules, containing 45 milligrams GLA and 360 milligrams LA (linoleic acid), have been taken by mouth daily for four months and then increased to four Efamol® capsules daily for an additional eight months.

For diabetic neuropathy (nerve damage), 360-480 milligrams of GLA have been taken by mouth daily for up to 12 months.

For dry eyes, six EPO capsules (Qarma™, Equazen™) have been taken by mouth daily for six months.

For eczema (atopic dermatitis), 1-4 EPO capsules (360 milligrams linoleic acid and 40-45 milligrams GLA per capsule) have been taken by mouth twice daily for up to 12 weeks. Additionally, 4-12 capsules (500 milligrams EPO per capsule) have been taken by mouth daily in two divided doses for up to five months (Efamol®). EPO doses have ranged from 0.5 grams-0.5 grams/kilogram taken by mouth for 3-16 weeks. A dose of 1 milliliter of 20% EPO has been applied to the skin twice daily for up to four months. EPO has been applied to the arms for two weeks.

For high cholesterol, four capsules, containing 0.3 grams EPO, have been taken by mouth three times daily for 16 weeks. Additionally, 1.5-2 grams of EPO has been taken by mouth twice daily for 1-3 months.

For liver cancer, 36 capsules, containing 500 milligrams EPO per capsule (Efamol®) daily (totaling 1.44 grams GLA daily) have been taken by mouth.

For liver disease, 2 grams of Efamol® has been taken by mouth twice daily for 12 weeks.

For lupus, 5 grams of EPO has been taken by mouth daily.

For premenstrual syndrome (PMS), 500-6,000 milligrams of EPO or 6-12 capsules EPO have been taken by mouth 1-4 times daily for up to 10 months (Efamol®).

For rheumatoid arthritis, 540-6,000 milligrams of EPO and 20-30 milliliters of EPO have been taken by mouth daily for 3-12 months.

For schizophrenia, 6-8 grams of EPO has been taken daily in divided doses. Eight Efamol® capsules have been taken by mouth daily for two to four months.

Children (younger than 18 years)

For eczema (atopic dermatitis), 1-12 capsules (500 milligrams EPO per capsule) have been taken by mouth daily in single or divided doses for up to five months, at a maximum of 0.5 grams/kilogram daily.

For diabetes, 2-4 EPO capsules (Efamol) have been taken by mouth daily for 4-8 months.

This evidence-based monograph was prepared by The Natural Standard Research Collaboration

www.naturalstandard.com